Recent studies show that advanced melanoma and colorectal cancer patients with non-V600 BRAF mutation have longer overall survival compared those with both V600E BRAF mutant and wild-type BRAF [39, 40]. The gene discussed is BRAF; the disease is colorectal cancer.